Publications by authors named "J R Wilder"

Background & Aims: Hepatitis B reactivation (HBVr) can occur due to a variety of immune-modulating exposures, including multiple drug classes and disease states. Antiviral prophylaxis can be effective in mitigating the risk of HBVr. In select cases, clinical monitoring without antiviral prophylaxis is sufficient for managing the risk of HBVr.

View Article and Find Full Text PDF

Objectives: Nearly half of older adults experience somnolence, but the link between medications with somnolence as an adverse effect and somnolence is unclear. This study investigated the association between polypharmacy and somnolence symptoms (excessive sleepiness or long sleep duration).

Methods: Data from the National Social Life, Health, and Aging Project (NSHAP) 2010-2011 was used to examine the concurrent use of medications with potential somnolence as an adverse effect and the prevalence of somnolence symptoms.

View Article and Find Full Text PDF

Background: Dual-task function is compromised among individuals with prodromal Alzheimer's disease (AD) and others at risk of developing AD. While exercise has been studied as a therapeutic candidate, the activity of social dance might promote dual-task rehabilitation as well or better than conventional exercise.

Objective: Compare effects of social dance versus home exercise on dual-task function and intervention adherence among individuals with increased risk of developing AD: survivors of breast cancer (BC) with chemotherapy-induced neuropathy (CIN).

View Article and Find Full Text PDF
Article Synopsis
  • - Morbidity and mortality rates from cirrhosis are rising, highlighting significant health disparities in care and access to liver transplantation.
  • - Key affected groups include racial and ethnic minorities, sexual and gender minorities, lower socioeconomic individuals, and underserved rural communities, leading to delays in diagnosis and treatment for liver diseases.
  • - Addressing these disparities requires comprehensive interventions across the entire care process for chronic liver disease to improve health equity and outcomes for all populations.
View Article and Find Full Text PDF